Evaluating HIV prevention effectiveness: The perfect as the enemy of the good

AIDS

Volumn 26, Issue 7, 2012, Pages 779-783

  Laga, Marie ^a   Rugg, Deborah ^b   Peersman, Greet ^c   Ainsworth, Martha ^d  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b OIOS   (United States)

^c TULANE UNIVERSITY   (United States)

^d WORLD BANK   (United States)

Author keywords

HIV prevention; impact evaluation; plausibility; randomized controlled trial

Indexed keywords

BEHAVIOR CHANGE; BEHAVIOR THERAPY; DISEASE TRANSMISSION; FOLLOW UP; HEALTH CARE QUALITY; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK REDUCTION; SEXUALLY TRANSMITTED DISEASE;

HIV INFECTIONS; HUMANS; PREVENTIVE HEALTH SERVICES; PROGRAM EVALUATION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84859971780     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e328351e7fb     Document Type: Review

References (49)

1. Sidibe M, Buse K. Fomenting a prevention revolution for HIV. Lancet 2010; 375:533-535.
2. UNAIDS. UNAIDS Global Report, (2010). http://www.unaids. org. [Accessed 6 February 2012].
3. Van Damme W, Kober K, Laga M. The real challenges for scaling up ART in sub-Saharan Africa. AIDS 2006; 20:653-656. (Pubitemid 43884291)
4. UNAIDS. Practical guidelines for intensifying HIV prevention. Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS, (2007). http://www.unaids.org. [Accessed 6 February 2012].
5. Schwartländer B, Stover J, Hallett T, Atun R, Avila C, Gouws E, et al. Toward an improved investment approach for an effective response to HIV/AIDS. Lancet 2011; 377:2031-2041.
6. Hankins CA, De Zalduondo BO. Combination prevention: a deeper understanding of effective HIV prevention. AIDS 2010; 24 (Suppl4):S70-S80.
7. Celentano DD, Nelson KE, Lyles CM, Beyrer C, Eiumtrakul S, Go VF, et al. Decreasing incidence of HIV and sexually transmitted diseases in young Thai men: evidence for success of the HIV/AIDS control and prevention program. AIDS 1998; 12:F29-F36. (Pubitemid 28116152)
8. Padian NS, Buvé A, Balkus J, Serwadda D, Cates W Jr. Biomedical interventions to prevent HIV infection: evidence, challenges, and way forward. Lancet 2008; 372:585-599.
9. Coates TJ, Richter L, Caceres C. Behavioural strategies to reduce HIV transmission: how to make them work better. Lancet 2008; 372:669-684.
10. Gupta GR, Parkhurst JO, Ogden JA, Aggleton P, Mahal A. Structural approaches to HIV prevention. Lancet 2008; 372:764-775.
11. Bertozzi SM, Laga M, Bautista-Arredondo S, Coutinho A. Making HIV prevention programmes work. Lancet 2008; 372:831-844.
12. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 365:493-505.
13. Kamali A, Quigley M, Nakiyingi J, Kinsman J, Kengeya-Kayondo J, Gopal R, et al. Syndromic management of sexually-transmitted infections and behaviour change interventions on transmission of HIV-1 in rural Uganda: a community randomised trial. Lancet 2003; 361:645-652. (Pubitemid 36246546)
14. Ross DA, Changalucha J, Obasi AI, Todd J, Plummer ML, Cleophas-Mazige B, et al. Biological and behavioural impact of an adolescent sexual health intervention in Tanzania: a community-randomized trial. AIDS 2007; 21:1943-1955. (Pubitemid 47329771)
15. Corbett EL, Makamure B, Cheung YB, Dauya E, Matambo R, Bandason T, et al. HIV incidence during a cluster-randomized trial of two strategies providing voluntary counselling and testing at the workplace, Zimbabwe. AIDS 2007; 21:483-489.
16. Jewkes R, Nduna M, Levin J, Jama N, Dunkle K, Puren A, Duvvury N. Impact of stepping stones on incidence of HIV and HSV-2 and sexual behaviour in rural South Africa: cluster randomised controlled trial. BMJ 2008; 337:a506.
17. Cowan FM, Pascoe SJS, Langhaug LF, Mavhu W, Chidiya S, Jaffar S, et al. The Regai Dzive Shiri Project: results of a randomized trial of an HIV prevention intervention for youth. AIDS 2010; 24:2541-2552.
18. Pronyk PM, Hargreaves JR, Kim JC, Morison LA, Phetla G, Watts C, et al. Effect of a structural intervention for the prevention of intimate-partner violence and HIV in rural South Africa: a cluster randomised trial. Lancet 2006; 368:1973-1983. (Pubitemid 44821362)
19. Gregson S, Adamson S, Papaya S, Mundondo J, Nyamukapa CA, Mason PR, et al. Impact and process evaluation of integrated community and clinic-based HIV-1 control: a cluster-randomised trial in eastern Zimbabwe. PLoS Med 2007; 4:e102.
20. UNAIDS. Strategic guidance for evaluating HIV prevention programmes. Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS, (2010). http://www.unaids.org. [Accessed 6 February 2012].
21. Habicht JP, Victora CG, Vaughan JP. Evaluation designs for adequacy, plausibility and probability of public health programme performance and impact. Int J Epidemiol 1999; 28:10-18. (Pubitemid 29086204)
22. Ravallion M. Should the randomistas rule? Economists' voice. (2009). Berkeley Electronic Press. http://www.bepress.com/ev. [Accessed 6 February 2012].
23. Ravallion M. Evaluating anti-poverty programs. In: Schultz TP, Strauss J, editors. Handbook of development economics. Amsterdam: North Holland; 2007.
24. Nutbeam D. Evaluating health promotion, progress, problems and solutions. Health Promot Int 1998; 13:27-43.
25. Kippax S, Van de Ven P. An epidemic of orthodoxy? Design and methodology in the evaluation of the effectiveness of HIV health promotion. Crit Public Health 1998; 8:371-386.
26. Van de Ven P, Aggleton P. What constitutes evidence in HIV/aids education? Health Educ Res 1999; 14:461-471. (Pubitemid 29389388)
27. Padian NS, Holmes CB, McCoy SI, Lyerla R, Bouey PD, Goosby EP. Implementation Science for the US President's Emergency Plan for AIDS Relief (PEPFAR). J Acquir Immune Defic Syndr 2011; 56:199-203.
28. Padian NS, McCoy SI, Balkus JE, Wasserheit JN. Weighing the gold in the gold standard: challenges in HIV prevention research. AIDS 2010; 24:621-635.
29. 'Impact Evaluation of Combination HIV Prevention Interventions in PEPFAR Countries', CDC funding opportunity, RFA-GH-11-006. http://www.cdc.gov/od/pgo/ funding/grants . [Accessed 22 December 2011].
30. Parekh BS, Kennedy MS, Dobbs T, Pau CP, Byers R, Green T, et al. Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence. AIDS Res Hum Retroviruses 2002; 18:295-307. (Pubitemid 34253148)
31. Hallett TB, Ghys P, Bärnighausen T, Yan P, Garnett GP. Errors in 'BED'-Derived Estimates of HIV Incidence will vary by place, time and age. Plos ONE 2009; 4:e5720; doi:10.1371/journal. pone.0005720.
32. Incidence Assay Critical Path Working Group. More and better information to tackle HIV epidemics: towards improved HIV incidence assays. Plos Medicine 2011; 8:e1001045.
33. Ghys PD, Kufa E, George MV. Measuring trends in prevalence and incidence of HIV infection in countries with generalised epidemics. Sex Transm Infect 2006; 82 (Suppl1):i52-i56; doi:10.1136/sti.2005.016428.
34. Ghys PD, Brown T, Grassly NC, Garnett G, Stanecki KA, Stover J, Walker N. The UNAIDS Estimation and Projection Package: a software package to estimate and project national HIV epidemics. Sex Transm Inf 2004; 80 (Suppl 1):i5-i9. (Pubitemid 39070777)
35. Hallett TB, Zaba B, Todd J, Lopman B, Mwita W, Biraro S, et al. Estimating incidence from prevalence in generalised epidemics. Plos Med 2008; 5:e80.
36. Peterman TA, Lin LS, Newman DR, Kamb ML, Bolan G, Zenilman J, et al. Does measured behavior reflect STD risk? An analysis of data from a randomized controlled behavioral intervention study. Project RESPECT Study Group. Sex Transm Dis 2000; 8:446-451. (Pubitemid 30666946)
37. Aral SO, Peterman TA. A stratified approach to untangling the behavioral/biomedical outcomes conundrum. Sex Transm Dis 2002; 9:530-532. (Pubitemid 35001342)
38. Victora CG, Habicht JP, Bryce J. Evidence-based public health: moving beyond randomized trials. Am J Public Health 2004; 3:400-40540.
39. Victora CG, Schellenberg JA, Huicho L, Amaral J, El Arifeen S, Pariyo G, et al. Context matters: interpreting impact findings in child survival evaluations. Health Policy Plan 2005; 20 (Suppl 1):i18-i31.
40. Kemm J. The limitations of 'evidence-based' public health. J Eval Clin Pract 2006; 12:319-324. (Pubitemid 43806711)
41. Chandrasekaran P, Dallabetta G, Loo V, Mills S, Saidel T, Adhikary R, et al. Evaluation Design For Large-Scale Hiv Prevention Programmes: the case of AVAHAN, the India AIDS initiative. AIDS 2008; 22:S1-S15.
42. Boily MC, Pickles M, Vickerman P, Buzdugan R, Isac S, Deering KN, et al. Using mathematical modelling to investigate the plausibility of attributing observed antenatal clinic declines to a female sex worker intervention in Karnataka state, India. AIDS 2008; 22 (Suppl 5):S149-S164.
43. Shadish WR, Cook TD, Campbell DT. Experimental and quasiexperimental designs for generalized causal inference. Boston: Houghton-Mifflin, 2002.
44. Halperin DT, Mugurungi O, Hallett TB, Muchini B, Campbell B, Magure T, et al.Asurprising prevention success:why did the HIV epidemic decline in Zimbabwe? Plos Med 2011; 8:e1000414.
45. Bartholomew LK, Parcel GS, Kok G, Gottlieb NH, Fernández ME. Planning health promotion programs: an intervention mapping approach, 3rd ed. San Francisco: Jossey Bass; 2011.
46. Verma R, Shekhar A, Khobragade S, Adhikary R, George B, Ramesh BM, et al. Scale-up and coverage of AVAHAN: a largescale HIV-prevention programme among female sex workers and men who have sex with men in four Indian states. Sex Transm Infect 2010; 86(Suppl 1):i76-i82.
47. Auerbach JD, Parkhurst JO, Caceres CF, Keller KE. Addressing social drivers of HIV/AIDS: some conceptual, methodological and evidentiary considerations. AIDS 2031; Working paper no. 24.
48. UNAIDS/WHO. Guidelines on estimating the size of populations most at risk to HIV. UNAIDS/WHO Working group on global HIV/AIDS and STI Surveillance. http://www.who.int. [Accessed 6 February 2012].
49. Vuylsteke B, Vandenhoudt H, Langat L, Semde G, Menten J, Odongo F, et al. Capture-recapture for estimating the size of the female sex worker population in three cities in Côte d'Ivoire and in Kisumu, western Kenya. Trop Med Int Health 2010; 15:1537-1543.